China Traditional Chinese Medicine Holdings Co. Limited
CHIZF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $3,731,692 | $8,124,235 | $8,385,473 | $8,818,904 |
| % Growth | -54.1% | -3.1% | -4.9% | – |
| Cost of Goods Sold | $1,914,395 | $4,329,181 | $4,324,219 | $4,302,388 |
| Gross Profit | $1,817,297 | $3,795,054 | $4,061,254 | $4,516,516 |
| % Margin | 48.7% | 46.7% | 48.4% | 51.2% |
| R&D Expenses | $128,062 | $328,082 | $267,925 | $372,018 |
| G&A Expenses | $250,272 | $272,757 | $256,075 | $289,282 |
| SG&A Expenses | $1,623,330 | $1,580,509 | $1,710,813 | $1,879,110 |
| Sales & Mktg Exp. | $1,278,200 | $1,333,307 | $1,376,329 | $1,608,141 |
| Other Operating Expenses | $83,750 | $1,935,451 | $1,697,935 | $1,652,157 |
| Operating Expenses | $1,835,141 | $3,844,042 | $3,676,672 | $3,903,285 |
| Operating Income | -$17,845 | -$48,988 | $384,582 | $613,231 |
| % Margin | -0.5% | -0.6% | 4.6% | 7% |
| Other Income/Exp. Net | -$23,625 | -$87,337 | -$85,148 | -$95,510 |
| Pre-Tax Income | -$41,470 | -$136,325 | $299,434 | $517,721 |
| Tax Expense | $29,411 | $57,047 | $85,291 | -$261,389 |
| Net Income | -$53,959 | -$156,912 | $210,979 | $706,458 |
| % Margin | -1.4% | -1.9% | 2.5% | 8% |
| EPS | -0.011 | -0.031 | 0.042 | 0.14 |
| % Growth | 65.7% | -174.5% | -70.1% | – |
| EPS Diluted | -0.011 | -0.031 | 0.042 | 0.14 |
| Weighted Avg Shares Out | 5,035,838 | 5,035,801 | 5,035,899 | 5,035,841 |
| Weighted Avg Shares Out Dil | 5,035,801 | 5,035,801 | 5,035,801 | 5,035,801 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $47,677 | $0 | -$8,880 |
| Interest Expense | $13,575 | $235,772 | $0 | -$39,446 |
| Depreciation & Amortization | $266,098 | $593,541 | $536,683 | $528,346 |
| EBITDA | $360,331 | $621,377 | $907,728 | $1,093,725 |
| % Margin | 9.7% | 7.6% | 10.8% | 12.4% |